This site uses cookies to provide a better browsing experience. More information can be found on our Privacy Policy page.

NodThera has changed its name to Rezera and announced a Phase 3 development program. Read Press Release

Newsroom

Stay informed on our latest company updates, scientific advancements, clinical milestones, and corporate announcements as we continue advancing NLRP3-based medicines.

Press Release

NodThera to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
Media Article

Geoff McDonough’s big plans for NodThera’s NLRP3

Endpoints
Press Release

NodThera Appoints Geoff McDonough, M.D., as Chief Executive Officer
Press Release

NodThera Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference
Press Release

NodThera Appoints Geoff McDonough, M.D., as Independent Board Member
Press Release

NodThera Announces Appointment of Chris Guiffre, J.D., M.B.A., as Chief Financial Officer

Join Our Team